Martin Auster
Stock Analyst at Raymond James
(4.51)
# 1,016
Out of 4,361 analysts
212
Total ratings
51.6%
Success rate
15%
Average return
Main Sectors:
Stocks Rated by Martin Auster
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EWTX Edgewise Therapeutics | Reiterated: Buy | $46 → $66 | $37.25 | +77.18% | 4 | Jun 1, 2026 | |
| EQ Equillium | Maintained: Buy | $6 → $7 | $2.79 | +150.90% | 2 | May 28, 2026 | |
| TECX Tectonic Therapeutic | Maintained: Buy | $76 → $81 | $27.43 | +195.30% | 2 | May 26, 2026 | |
| BBIO BridgeBio Pharma | Downgraded: Hold | n/a | $63.88 | - | 4 | May 26, 2026 | |
| SYRE Spyre Therapeutics | Initiated Coverage: Buy | $80 | $69.16 | +15.67% | 1 | Apr 10, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $53 → $60 | $44.68 | +34.29% | 5 | Mar 30, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $48 → $56 | $24.29 | +130.55% | 2 | Mar 25, 2026 | |
| EVMN Evommune | Reiterated: Buy | $40 | $19.82 | +101.82% | 2 | Jan 26, 2026 | |
| WVE Wave Life Sciences | Reiterated: Buy | $21 → $26 | $5.69 | +356.94% | 4 | Jan 13, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $108 → $117 | $68.00 | +72.06% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $29.92 | +27.01% | 1 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $9.65 | +190.16% | 1 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $271 | $216.60 | +25.12% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $35 | $17.24 | +103.02% | 3 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 → $424 | $286.12 | +48.19% | 2 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $70.91 | - | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $6 | $49.30 | n/a | 3 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $102 → $100 | $53.32 | n/a | 14 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $3.14 | n/a | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $8 | $6.58 | n/a | 4 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 → $12 | $22.95 | n/a | 2 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 → $58 | $28.68 | n/a | 6 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $156 → $72 | $16.25 | n/a | 23 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $169 → $196 | $540.05 | n/a | 17 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 → $98 | $1.78 | n/a | 5 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 → $99 | $21.78 | n/a | 15 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $60 | $103.73 | n/a | 17 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $54 | $68.23 | n/a | 12 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $76 → $78 | $26.76 | n/a | 5 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $45 | $3.14 | n/a | 11 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $12 | $3.28 | n/a | 9 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $24 | $13.13 | n/a | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $43 | $8.97 | n/a | 4 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $492.00 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $14 | $1.05 | n/a | 4 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $3.02 | n/a | 4 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $51.26 | n/a | 8 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $4 | $0.0001 | n/a | 3 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $1.16 | n/a | 1 | Jan 18, 2018 |
Edgewise Therapeutics
Jun 1, 2026
Reiterated: Buy
Price Target: $46 → $66
Current: $37.25
Upside: +77.18%
Equillium
May 28, 2026
Maintained: Buy
Price Target: $6 → $7
Current: $2.79
Upside: +150.90%
Tectonic Therapeutic
May 26, 2026
Maintained: Buy
Price Target: $76 → $81
Current: $27.43
Upside: +195.30%
BridgeBio Pharma
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $63.88
Upside: -
Spyre Therapeutics
Apr 10, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $69.16
Upside: +15.67%
Scholar Rock Holding
Mar 30, 2026
Reiterated: Buy
Price Target: $53 → $60
Current: $44.68
Upside: +34.29%
Maze Therapeutics
Mar 25, 2026
Reiterated: Buy
Price Target: $48 → $56
Current: $24.29
Upside: +130.55%
Evommune
Jan 26, 2026
Reiterated: Buy
Price Target: $40
Current: $19.82
Upside: +101.82%
Wave Life Sciences
Jan 13, 2026
Reiterated: Buy
Price Target: $21 → $26
Current: $5.69
Upside: +356.94%
Disc Medicine
Jan 13, 2026
Reiterated: Buy
Price Target: $108 → $117
Current: $68.00
Upside: +72.06%
Dec 19, 2025
Initiated Coverage: Buy
Price Target: $38
Current: $29.92
Upside: +27.01%
Dec 11, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $9.65
Upside: +190.16%
Oct 17, 2025
Initiated Coverage: Buy
Price Target: $271
Current: $216.60
Upside: +25.12%
Aug 25, 2025
Maintained: Buy
Price Target: $31 → $35
Current: $17.24
Upside: +103.02%
Aug 1, 2025
Initiated Coverage: Buy
Price Target: $55 → $424
Current: $286.12
Upside: +48.19%
Jul 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $70.91
Upside: -
Nov 16, 2021
Maintained: Buy
Price Target: $26 → $6
Current: $49.30
Upside: n/a
Oct 28, 2021
Maintained: Buy
Price Target: $102 → $100
Current: $53.32
Upside: n/a
Mar 22, 2021
Initiated Coverage: Buy
Price Target: $26
Current: $3.14
Upside: n/a
Mar 16, 2021
Maintained: Hold
Price Target: $7 → $8
Current: $6.58
Upside: n/a
Mar 16, 2021
Maintained: Buy
Price Target: $29 → $12
Current: $22.95
Upside: n/a
Mar 10, 2021
Maintained: Buy
Price Target: $49 → $58
Current: $28.68
Upside: n/a
Mar 2, 2021
Maintained: Hold
Price Target: $156 → $72
Current: $16.25
Upside: n/a
Feb 22, 2021
Maintained: Buy
Price Target: $169 → $196
Current: $540.05
Upside: n/a
Feb 11, 2021
Maintained: Buy
Price Target: $62 → $98
Current: $1.78
Upside: n/a
Jan 25, 2021
Maintained: Hold
Price Target: $64 → $99
Current: $21.78
Upside: n/a
Jan 19, 2021
Reiterated: Buy
Price Target: $50 → $60
Current: $103.73
Upside: n/a
Jan 11, 2021
Maintained: Hold
Price Target: $53 → $54
Current: $68.23
Upside: n/a
Nov 20, 2020
Maintained: Buy
Price Target: $76 → $78
Current: $26.76
Upside: n/a
Nov 10, 2020
Upgraded: Buy
Price Target: $45
Current: $3.14
Upside: n/a
Nov 6, 2020
Maintained: Hold
Price Target: $11 → $12
Current: $3.28
Upside: n/a
Nov 5, 2020
Maintained: Hold
Price Target: $21 → $24
Current: $13.13
Upside: n/a
Oct 8, 2020
Maintained: Buy
Price Target: $27 → $43
Current: $8.97
Upside: n/a
Sep 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $492.00
Upside: n/a
Sep 15, 2020
Maintained: Sell
Price Target: $14
Current: $1.05
Upside: n/a
Aug 3, 2020
Maintained: Hold
Price Target: $5
Current: $3.02
Upside: n/a
Jul 7, 2020
Maintained: Hold
Price Target: $16
Current: $51.26
Upside: n/a
Nov 7, 2019
Downgraded: Hold
Price Target: $16 → $4
Current: $0.0001
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $1.16
Upside: n/a